...
首页> 外文期刊>Frontiers in Medicine >Myricetin Modulates Macrophage Polarization and Mitigates Liver Inflammation and Fibrosis in a Murine Model of Nonalcoholic Steatohepatitis
【24h】

Myricetin Modulates Macrophage Polarization and Mitigates Liver Inflammation and Fibrosis in a Murine Model of Nonalcoholic Steatohepatitis

机译:Myricetin调节巨噬细胞极化和减轻非酒精性脂肪肝炎的小鼠模型中的肝脏炎症和纤维化

获取原文

摘要

This study aimed to investigate the beneficial effects of myricetin in a diet-induced nonalcoholic steatohepatitis (NASH) model and the underlying mechanism. C57BL/6J mice were fed a standard chow or the choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD) for 8 weeks with the treatment of myricetin (100 mg/kg) or vehicle by daily gavage. Hepatic inflammation, steatosis, fibrosis, and hepatic stellate cells (HSC) activation were assessed. We also analyzed M1 and M2 macrophages and its related markers in livers from NASH mice and in RAW264.7 macrophages stimulated by lipopolysaccharide (LPS) or interleukin 4 (IL-4) in vitro. Furthermore, we determined the effect of myricetin on the triggering receptor expressed on myeloid cells-1 (TREM-1), toll like receptor (TLR) 2 and 4, and myeloid differentiation factor 88 (MyD88) signaling both in livers from mice and in RAW264.7 cells stimulated by LPS. Our results revealed that myricetin remarkably ameliorated hepatic steatosis, inflammation, and inhibited hepatic macrophage infiltration in CDAHFD-fed mice. Myricetin-treated to CDAHFD-fed mice also inhibited liver fibrosis and HSC activation when compared with vehicle-treated to those mice. Moreover, myricetin inhibited M1 macrophage polarization and its relative markers in livers of NASH mice while induced M2 polarization. Similarly, in vitro study, myricetin inhibited the LPS-induced mRNA expression of M1 macrophages marker genes and induced IL-4-induced M2 macrophage marker genes in RAW264.7 macrophages. Mechanically, myricetin inhibited the expression of TREM-1 and TLR2/4-MyD88 signaling molecules in livers from NASH mice and in RAW264.7 macrophages stimulated by LPS in vitro. Additionally, myricetin inhibited the activation of nuclear factor (NF)-κB signaling and the phosphorylation of the signal transducer and activation of transcription 3 (STAT3) in LPS-stimulated RAW264.7 macrophages. Taken together, our data indicated that myricetin modulated the polarization of macrophages via inhibiting the TREM-1-TLR2/4-MyD88 signaling molecules in macrophages and therefore mitigated NASH and hepatic fibrosis in the CDAHFD-diet-induced NASH model in mice.
机译:本研究旨在探讨Myricetin在饮食诱导的非酒精性脂肪疏皮性(NASH)模型和潜在机制中的有益作用。将C57BL / 6J小鼠用每日饲养治疗Myricetin(100mg / kg)或载体,将标准食用含量或胆碱缺陷,L-氨基酸定义的高脂饮食(CDAHFD)喂养8周。评估肝脏炎症,脂肪变性,纤维化和肝星状细胞(HSC)活化。我们还分析了从腹水和Rah264.7在体外通过脂多糖(LPS)或白细胞介素4(IL-4)刺激的肝脏和Raw264.7巨噬细胞的M1和M2巨噬细胞及其相关标记。此外,我们确定了Myricetin对骨髓细胞-1-1(Trem-1),损伤等受体(TLR)2和4的触发受体(TLR)2和4的触发受体的影响,并且粘骨分化因子88(MYD88)信号传递给来自小鼠的肝脏和IN RAW264.7细胞受LPS刺激。我们的研究结果表明,Myricetin显着改善了肝脏脂肪变性,炎症和抑制CDAHFD-FED小鼠的肝巨噬细胞浸润。与那些小鼠的载体处理相比,Myricetin治疗到CDAHFD喂食小鼠的肝纤维化和HSC活化也抑制了肝纤维化和HSC活化。此外,Myricetin在诱导M2极化的同时抑制腹腔小鼠肝脏中的M1巨噬细胞极化及其相对标记。类似地,在体外研究中,Myricetin抑制了M1巨噬细胞标志物基因的LPS诱导的mRNA表达,并在Raw264.7巨噬细胞中诱导IL-4诱导的M2巨噬细胞标记基因。机械地,Myricetin抑制来自腹腔小鼠和RAW264.7在体外刺激的RAP264.7巨噬细胞中的TREM-1和TLR2 / 4-MYD88信号分子的表达。另外,Myricetin抑制了核因子(NF)-κB信号传导的激活和信号传感器的磷酸化和LPS刺激的Raw264.7巨噬细胞中的转录3(STAT3)的激活。我们的数据表明,Myricetin通过抑制巨噬细胞中的Trem-1-TLR2 / 4-MyD88信号分子和因此在小鼠中CDAHFD - 饮食诱导的桡骨模型中的减少的肿瘤和肝纤维化来调节巨噬细胞的极化。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号